139 related articles for article (PubMed ID: 36203374)
1. Renal insulin resistance in type 2 diabetes mellitus and progression of chronic kidney disease: potential pathogenic mechanisms.
Alqallaf A; Swan P; Docherty NG
Expert Rev Endocrinol Metab; 2022 Nov; 17(6):523-532. PubMed ID: 36203374
[TBL] [Abstract][Full Text] [Related]
2. The relationship between chronic kidney function and homeostasis model assessment of insulin resistance and beta cell function in Korean adults with or without type 2 diabetes mellitus.
Kim GS; Kim SG; Kim HS; Hwang EY; Lee JH; Yoon H
Endocr J; 2017 Dec; 64(12):1181-1190. PubMed ID: 28890482
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease.
Kelly MS; Lewis J; Huntsberry AM; Dea L; Portillo I
Postgrad Med; 2019 Jan; 131(1):31-42. PubMed ID: 30449220
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].
Wu W; Yang JJ; Wan YG; Tu Y; Shi G; Han WB; Liu BH; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):49-55. PubMed ID: 28945024
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in chronic kidney disease: a systematic review.
Spoto B; Pisano A; Zoccali C
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.
Schrauben SJ; Jepson C; Hsu JY; Wilson FP; Zhang X; Lash JP; Robinson BM; Townsend RR; Chen J; Fogelfeld L; Kao P; Landis JR; Rader DJ; Hamm LL; Anderson AH; Feldman HI
BMC Nephrol; 2019 Feb; 20(1):60. PubMed ID: 30786864
[TBL] [Abstract][Full Text] [Related]
7. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
[TBL] [Abstract][Full Text] [Related]
8. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.
Marchelek-Mysliwiec M; Dziedziejko V; Dolegowka K; Pawlik A; Safranow K; Stepniewska J; Wisniewska M; Malyszko J; Ciechanowski K
J Appl Biomed; 2020 Aug; 18(2-3):61-69. PubMed ID: 34907727
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance as a therapeutic target for chronic kidney disease.
Teta D
J Ren Nutr; 2015 Mar; 25(2):226-9. PubMed ID: 25511524
[TBL] [Abstract][Full Text] [Related]
10. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.
Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B
Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758
[TBL] [Abstract][Full Text] [Related]
12. The relationship among renal injury, changed activity of renal 1-alpha hydroxylase and bone loss in elderly rats with insulin resistance or Type 2 diabetes mellitus.
Huang CQ; Ma GZ; Tao MD; Ma XL; Liu QX; Feng J
J Endocrinol Invest; 2009 Mar; 32(3):196-201. PubMed ID: 19542734
[TBL] [Abstract][Full Text] [Related]
13. The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.
Zhang Y; Wang J; Ren Y; Yan WF; Jiang L; Li Y; Yang ZG
Cardiovasc Diabetol; 2021 Jan; 20(1):11. PubMed ID: 33413395
[TBL] [Abstract][Full Text] [Related]
14. Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats.
Xu Z; Zhang L; Li J; Zhao Y; Chen X
Kidney Blood Press Res; 2018; 43(4):1199-1211. PubMed ID: 30071523
[TBL] [Abstract][Full Text] [Related]
15. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.
Liu JJ; Liu S; Gurung RL; Ang K; Tang WE; Sum CF; Tavintharan S; Lim SC
Nephrol Dial Transplant; 2020 Jan; 35(1):115-121. PubMed ID: 30007296
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and brain-derived neurotrophic factor levels in chronic kidney disease.
Marchelek-Myśliwiec M; Cichocka E; Dziedziejko V; Dutkiewicz GŻ; Stępniewska J; Safranow K; Budkowska M; Sałata D; Syrenicz A; Machaliński B; Ciechanowski K
Ann Clin Biochem; 2015 Mar; 52(Pt 2):213-9. PubMed ID: 24833633
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes.
Duan S; Lu F; Wu B; Zhang C; Nie G; Sun L; Huang Z; Guo H; Zhang B; Xing C; Yuan Y
Front Endocrinol (Lausanne); 2022; 13():929598. PubMed ID: 35846303
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
19. Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology.
Sinha S; Haque M
Cureus; 2022 Sep; 14(9):e28944. PubMed ID: 36111327
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.
Tong L; Adler S
Postgrad Med; 2018 May; 130(4):381-393. PubMed ID: 29667921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
